A prospective observational study of prescription pattern of antihypertensive drugs in general medicine outpatient department of associated hospital RUHS CMS, Jaipur
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20232564Keywords:
Antihypertensive drug prescription patterns, JNC-8Abstract
Background: The increasing prevalence of hypertension is attributed to population growth, ageing and behavioural risk factors, such as unhealthy diet, harmful use of alcohol, lack of physical activity, excess weight and exposure to persistent stress. The aim of study is the prescribing pattern and the consumption of antihypertensive drugs in isolated hypertensive patients and in hypertensive patients with different co-existing morbidities.
Methods: The present study is a Prospective observational study. The study was conducted at Medicine Department of associated hospital of RUHS College of Medical Sciences, Jaipur.
Results: A total of 965 patients having hypertension were analyzed, in that 556 patients were male and 409 patients were female. In hypertension patients, angiotensin receptor blockers ARB, diuretics and β- blockers (29.90%) were mostly used classes in three drug therapy. Whereas telmisartan, hydrochlorothiazide and metoprolol (35.05%) were mostly prescribed. Drugs. In hypertension patients, angiotensin receptor blockers ARB, diuretics, β- blockers and calcium channel blockers (56.67%) and calcium channel blockers, angiotensin converting enzyme inhibitors, β-blockers and diuretics (43.33%) were used classes in four drug therapy. Whereas Telmisartan, Hydrochlorothiazide, Nebivolol and Amlodipine (62.5%) were mostly prescribed drugs. Hypertensive Patients with Comorbidity were found in higher prevalence with 276 hypertensive patients (28.60%) along with Diabetes Mellitus most commonly found and 389 hypertensive patients (40.31%) were found to be with No Comorbidity.
Conclusions: Present results reveal that antihypertensive medication adherence to JNC-8 recommendations is suboptimal. Therefore, physicians should follow JNC-8 guidelines to improve the patients care because suboptimal adherence leads to adverse clinical outcomes. The present study demonstrated that physicians are not completely adhering to standard guidelines while treating hypertension with co-morbid conditions.
Metrics
References
Grossman E, MesserliFH. Blood pressure and mortality. J Am Coll Cardiol. 2002;39(6):981-8.
Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;56(5):796-801.
Pickering TG. The history of blood pressure measurement. J ClinHypertens (Greenwich). 2006; 8(12):848-52.
Hall JE, Granger JP, do CarmoJM, da Silva AA, Dubinion J, George E, et al. Hypertension: physiology and pathophysiology. Compr Physiol. 2012;2(4):2393-442.
Kario K. Essential hypertension as a multifactorial disease: evidence from the Japanese experience. Am J Hypertens. 2014;27(3):287-9.
Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Hara K, et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346(25):1954-62.
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2): 199-206.
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489): 895-906.
Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043-50.
Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ. 2013;3(8):e003423.
Wang JG, Li Y, Franklin SS. Factors contributing to hypertension control in the general population of South-East Asia: a report from the Adherence to Medications in Chronic Diseases Network (ACCORD). J Hum Hypertens. 2018;32(10):657-67.
Blood Pressure. Available at: https://www.nhlbi. nih.gov/health-topics/high-blood-pressure/clinical-guidelines-for-high-blood-pressure. Accessed on 20 February 2023.
Chobanian AV, Bakris GL, Black HR. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289(19):2560-72.
Rachana PR, Anuradha HV, Shivamurthy MC. Antihypertensive prescribing patterns and cost analysis for primary hypertension: A retrospective study. J Clin Diagn Res. 2014;8(9):19-22.
Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004;45(3):117-20.
Pai PG, Shenoy J, Sanji N. Prescribing patterns of antihypertensive drugs in a South Indian tertiary care hospital. Drug Invent Today. 2011;3(4):38-40.
Etuk E, Isezuo SA, Chika A, AkucheJ, Ali M. Prescription pattern of antihypertensive drugs in a tertiary health institution in Nigeria. Annal Afr Med. 2008;7(3):128-32.
Mankadavath A, Chandrasekhar D, Thomas T, Zuhra F, Kaipanthodi S, Parambil JC. A prospective drug use evaluation of antihypertensive drugs in in-patients of a tertiary referral care hospital. J Basic Clin Physiol Pharmacol. 2014;26(3):1-6.
Rajasekhar DG, Prasana DG, Chandrakanth P. Prescribing pattern of antihypertensive drugs based on compelling indications with hypertension. Int J Pharm Pharm Sci. 2013;8(2):72-5.